
Liquidity, historical trends, and peer comparisons.
According to Nxera Pharma Co., Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 2.56. This represents a change of -1.35% compared to the average of 2.59 of the last 4 quarters.
The mean historical Current Ratio of Nxera Pharma Co., Ltd. over the last ten years is 7.04. The current 2.56 Current Ratio has changed -63.66% with respect to the historical average. Over the past ten years (40 quarters), SOLTF's Current Ratio was at its highest in in the September 2022 quarter at 20.73. The Current Ratio was at its lowest in in the December 2016 quarter at 2.51.
Average
7.04
Median
4.40
Minimum
2.54
Maximum
17.09
Discovering the peaks and valleys of Nxera Pharma Co., Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 107.71%
Maximum Annual Current Ratio = 17.09
Minimum Annual Increase = -77.83%
Minimum Annual Current Ratio = 2.54
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 2.54 | -31.35% |
| 2024 | 3.70 | -2.32% |
| 2023 | 3.79 | -77.83% |
| 2022 | 17.09 | 95.69% |
| 2021 | 8.73 | -37.95% |
| 2020 | 14.08 | 65.71% |
| 2019 | 8.49 | 107.71% |
| 2018 | 4.09 | -13.03% |
| 2018 | 4.70 | 48.54% |
| 2017 | 3.17 | 2.93% |
The current Current Ratio of Nxera Pharma Co., Ltd. (SOLTF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
3.34
5-year avg
7.17
10-year avg
7.04
Nxera Pharma Co., Ltd.’s Current Ratio is greater than Astellas Pharma Inc. (1.20), less than Daiichi Sankyo Company, Limited (2.70), less than Chugai Pharmaceutical Co., Ltd. (6.39), greater than Shionogi & Co., Ltd. (1.24), less than Kyowa Kirin Co., Ltd. (3.21), less than Ono Pharmaceutical Co., Ltd. (3.32), greater than Eisai Co., Ltd. (2.24), greater than Sumitomo Pharma Co., Ltd. (1.36), less than Santen Pharmaceutical Co., Ltd. (2.82), less than KYORIN Holdings, Inc. (5.18),
| Company | Current Ratio | Market cap |
|---|---|---|
| 1.20 | $4.79T | |
| 2.70 | $5.61T | |
| 6.39 | $11.83T | |
| 1.24 | $2.72T | |
| 3.21 | $1.37T | |
| 3.32 | $1.17T | |
| 2.24 | $1.49T | |
| 1.36 | $932.63B | |
| 2.82 | $604.65B | |
| 5.18 | $66.01B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nxera Pharma Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Nxera Pharma Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Nxera Pharma Co., Ltd.'s Current Ratio?
How is the Current Ratio calculated for Nxera Pharma Co., Ltd. (SOLTF)?
What is the highest Current Ratio for Nxera Pharma Co., Ltd. (SOLTF)?
What is the 3-year average Current Ratio for Nxera Pharma Co., Ltd. (SOLTF)?
What is the 5-year average Current Ratio for Nxera Pharma Co., Ltd. (SOLTF)?
How does the current Current Ratio for Nxera Pharma Co., Ltd. (SOLTF) compare to its historical average?